The long term objective of this work is to predict the structure and energetics of protein-ligand non-covalent and covalent interactions. By comparison with appropriate solution phase interactions and binding and catalysis using organic biomimetic models, the nature of enzyme catalysis will be better understood. This understanding should lead to new ideas in site-directed mutagenesis approaches to enzyme design, as well as new biomimetic models to match the catalytic efficiency of protein enzymes. These studies will also lead to new ideas on the design of non-covalent and covalent enzyme inhibitors as transition state analogs. Since such inhibitors are of great potential medical importance (e.g., angiotensin converting enzyme inhibitors to combat hypertension), the studies proposed here could have an important impact on human medicine. We propose to develop a combined quantum/molecular mechanical methodology for the study of protein-ligand interactions, in which ab initio methods are used for the chemically reacting groups, combined with a molecular mechanical representation of both protein and water solvent. The solvent will be represented explicitly with accurate analytical potentials. The focus of the studies here will be on the serine and sulfhydryl proteases, on triose phosphate isomerase, as an example of a phosphate-binding enzyme, on staphylococcal nuclease, as an example of phosphate hydrolase and on adenylate kinase, as an example of a phosphate kinase. This particular set of proteins are being studied not only because their properties provide an important and stringent test for the theoretical methodologies, but also because of their physiological importance.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM029072-07
Application #
3276539
Study Section
Biophysics and Biophysical Chemistry A Study Section (BBCA)
Project Start
1982-02-01
Project End
1989-01-31
Budget Start
1988-02-01
Budget End
1989-01-31
Support Year
7
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Pharmacy
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Minehardt, T J; Kollman, P A; Cooke, R et al. (2006) The open nucleotide pocket of the profilin/actin x-ray structure is unstable and closes in the absence of profilin. Biophys J 90:2445-9
Wang, Junmei; Kang, Xinshan; Kuntz, Irwin D et al. (2005) Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA. J Med Chem 48:2432-44
Duan, Yong; Wu, Chun; Chowdhury, Shibasish et al. (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 24:1999-2012
Chong, Lillian T; Bandyopadhyay, Pradipta; Scanlan, Thomas S et al. (2003) Direct hydroxide attack is a plausible mechanism for amidase antibody 43C9. J Comput Chem 24:1371-7
Naber, Nariman; Minehardt, Todd J; Rice, Sarah et al. (2003) Closing of the nucleotide pocket of kinesin-family motors upon binding to microtubules. Science 300:798-801
Gouda, Hiroaki; Kuntz, Irwin D; Case, David A et al. (2003) Free energy calculations for theophylline binding to an RNA aptamer: Comparison of MM-PBSA and thermodynamic integration methods. Biopolymers 68:16-34
Masukawa, Kevin M; Kollman, Peter A; Kuntz, Irwin D (2003) Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations. J Med Chem 46:5628-37
Massova, Irina; Kollman, Peter A (2002) pKa, MM, and QM studies of mechanisms of beta-lactamases and penicillin-binding proteins: acylation step. J Comput Chem 23:1559-76
Dixon, Richard W; Radmer, Randall J; Kuhn, Bernd et al. (2002) Theoretical and experimental studies of biotin analogues that bind almost as tightly to streptavidin as biotin. J Org Chem 67:1827-37
Huo, Shuanghong; Massova, Irina; Kollman, Peter A (2002) Computational alanine scanning of the 1:1 human growth hormone-receptor complex. J Comput Chem 23:15-27

Showing the most recent 10 out of 81 publications